Opexa Therapeutics, Inc. OPXA
Set alert
No live quote for OPXA yet.
- Open
- 1.15
- Prev close
- 1.07
- Mkt cap
- 7.43M
- Vol
- 307.28K
- Avg vol
- 193.66K
- EPS
- -0.722
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.96
- High
- 1.16
- Forward P/E
- -4.41
- Beta
- 2.09
- Short ratio
- 0.45
- Inst. own
- 3.30%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.03
- 200-d avg
- 0.761182
- 1y target
- 1.00
Analyst view
Consensus: hold
Hold
Price target (mean) 1.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.12 | -0.12 – -0.12 | -0.28 | +57.1% | 0 | 0.0% | 1 |
| Next quarter | -0.12 | -0.12 – -0.12 | -0.09 | -33.3% | 0 | 0.0% | 1 |
| Current year | -0.47 | -0.47 – -0.47 | -0.98 | +52.0% | 0 | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -0.47 | 0.0% | 10.00M | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2016 | Aegis Capital | Downgrade | — | Hold |
| Oct 27, 2016 | Chardan Capital | Downgrade | — | Neutral |
| Nov 3, 2015 | Chardan Capital | Initiated | — | Buy |
| May 25, 2015 | Maxim Group | Initiated | — | Buy |
| May 29, 2014 | Aegis Capital | Initiated | — | Buy |
| Mar 23, 2014 | Brinson Patrick | Initiated | — | Outperform |